Drug Genius
368 posts
Drug Genius Staff Writer
Posts By Drug Genius
Polydex Pharmaceuticals Issues First Quarter Financial Results
Company Remains Profitable During Global Reduction In BusinessTORONTO, June 15, 2020 (GLOBE NEWSWIRE) — Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to…
Share
Phathom Pharmaceuticals Provides Clinical Trial Status Update
First New Patients Randomized in PHALCON-EE and PHALCON-HP Trials Since Temporary Pause Announced in MarchFLORHAM PARK, N.J., June 15, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc…
Share
PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service
RALEIGH, N.C., June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with…
Share
CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is Next
VANCOUVER, Washington, June 11, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5…
Share
Lexapro – Uses, Side Effects, Dosage & Interactions
Generic Name: Escitalopram oxalateBrands: LexaproClass: Selective serotonin reuptake inhibitor (SSRI)Availability: Prescription onlyMolecular Formula: C20H21FN2OSubstance UNII…
Share
RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib
The multi-center, randomized, double-blind, parallel-arm, placebo-controlled Phase 2/3 clinical study of opaganib for severe COVID-19 patients is planned to be conducted in Russia and…
Share
Drs. Pourhassan and Kelly of CytoDyn to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of Leronlimab in 2020-2021
VANCOUVER, Washington, June 09, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5…
Share
Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
GAITHERSBURG, Md., June 08, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases…
Share
Cytokinetics to Participate In Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif.,, June 08, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is…
Share
New Book Surveys Biotechnology Thought-Leaders on COVID-19
Free worldwide in the Amazon Kindle store June 8-12 NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) — RosettaBooks announced today the publication of Biotechnology in the Time of COVID-19…
Share